The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation

FEBS Letters

Volumn 431, Issue 2, 1998, Pages 185-188

  Cabot, Myles C ^a   Han, Tie Yan ^a   Giuliano, Armando E ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

Cancer; Ceramide; Cyclosporin; Multidrug resistance; SDZ PSC 833

Indexed keywords

CERAMIDE; CYCLOSPORIN A; FUMONISIN B1; SPHINGOMYELIN; VALSPODAR;

ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CULTURE MEDIUM; CYTOTOXICITY; DOSE RESPONSE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; METABOLISM; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY; TUMOR CELL;

MINK CELL FOCUS-FORMING VIRUS; SALVELINUS;

EID: 0032541179     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00744-3     Document Type: Article

References (22)

1. Gottesman, M.M. and Pasta, I. (1993) Biochim. Biophys. Acta 948, 385-427.
2. Bradley, G. and Ling, V. (1994) Cancer Metast. Rev. 13, 223-233.
3. Yusa, K. and Tsuruo, T. (1989) Cancer Res. 49, 5002-5006.
4. Foxwell, B.M., Mackie, A., Ling, V. and Ryffel, B. (1989) Mol. Pharmacol. 8, 985-994.
5. Callaghan, R. and Higgins, C.F. (1995) Br. J. Cancer 71, 294-299.
6. Cabot, M.C., Giuliano, A.E., Volner, A. and Han, T.-Y. (1996) FEBS Lett. 394, 129-131.
7. Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A.E. and Cabot, M.C. (1997) J. Biol. Chem. 272, 1682-1687.
8. Hannun, Y.A. and Obeid, L.M. (1997) Adv. Exp. Med. Biol. 407, 145-149.
9. Lutzker, S.G. and Levine, A.J. (1996) Cancer Treat. Res. 87, 345-346.
10. Slater, L.M., Sweet, P., Stupecky, M. and Gupta, S. (1986) J. Clin. Invest. 77, 1405-1408.
11. Gaveriaux, C., Boesch, D., Jachez, B., Bollinger, P., Payne, T. and Loor, F. (1991) J. Cell Pharmacol. 2, 225-234.
12. Twentyman, P.R. and Bleehen, N.M. (1991) Eur. J. Cancer 27, 1639-1642.
13. Archinal-Mattheis, A., Rzepka, R.W., Watanabe, T., Kokubu, N., Itoh, Y., Combates, N.J., Bair, K.W. and Cohen, D. (1995) Oncol. Res. 7, 603-610.
14. Bligh, E.G. and Dyer, W.T. (1959) Can. J. Biochem. Physiol. 37, 911-917.
15. Lucci, A., Giuliano, A.E. and Cabot, M.C. (1997) Proc. Am. Soc. Clin. Oncol. 16, 243a.
16. Wiesner, D.A., Kilkus, J.P., Gottschalk, A.R., Quintans, J. and Dawson, G. (1997) J. Biol. Chem. 272, 9868-9876.
17. Bose, R., Verjehi, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z. and Kolesnick, R. (1995) Cell 82, 405-414.
18. Bohme, M., Buchler, M., Muller, M. and Keppler, D. (1993) FEBS Lett. 333, 193-196.
19. Speeg, K.V. and Maldonado, A.L. (1994) Cancer Chemother. Pharmacol. 34, 133-136.
20. Prinetti, A., Bassi, R., Riboni, L. and Tettamanti, G. (1997) FEBS Lett. 414, 475-479.
21. Haimovitz-Friedman, A., Kan, C.C., Ehleiter, D., Persaud, R.S., McLoughlin, M., Fuks, Z. and Kolesnick, R.N. (1994) J. Exp. Med. 180, 525-535.
22. Cifone, M.G., DeMaria, R., Roncaioli, P., Rippo, M.R., Axuma, M., Lanier, L.L., Sanoni, A. and Testi, R. (1994) J. Exp. Med. 177, 1547-1552.